... responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. 2024 Visual Abstract Primary gout Hyperechoic medulla Renal ultrasound Chronic kidney disease Gouty nephropathy Gout...

...Charles W. Bishop; Akhtar Ashfaq; Stephen A. Strugnell; John Choe; Nilay Patel; Keith C. Norris; Stuart M. Sprague Introduction: Chronic kidney disease (CKD) drives onerous human and healthcare costs, underscoring an urgent need to avert disease progression. Secondary hyperparathyroidism (SHPT...

... Jauré; Manfred Hecking Introduction: Chronic kidney disease (CKD) in stages 3–5 without albuminuria occurs more often in women than in men; however, most patients initiating and receiving kidney replacement therapy are men. Sex-determined biological factors and gender-related aspects both likely account...

...Carol Pollock; Juan-Jesus Carrero; Eiichiro Kanda; Richard Ofori-Asenso; Ewelina Palmer; Anna Niklasson; Andrew Linder; Helen Woodward; Surendra Pentakota; Juan Jose Garcia Sanchez; Naoki Kashihara; Steven Fishbane; Roberto Pecoits-Filho; David C. Wheeler Introduction: Chronic kidney disease (CKD...

... failure with reduced ejection fraction (HFrEF) and chronic kidney disease (CKD); however, the risk of hyperkalemia (HK) is high. Methods: The DIAMOND trial (NCT03888066) assessed the ability of patiromer to control serum potassium (sK + ) in patients with HFrEF with/without CKD. Prior to randomization...

...Olil Van Reeth; Ancuta Caliment; Isabel de la Fuente Garcia; Olivier Niel Introduction: Nephroprotection in pediatric chronic kidney disease (CKD) has a major positive impact, both on residual renal function and on quality of life, by delaying the need for renal replacement therapy. To this day...

...Matthew R. Weir Background: Proton pump inhibitors (PPIs) are commonly prescribed medications for dyspepsia and gastroesophageal reflux. There are concerns about their use in the development of chronic kidney disease (CKD). Summary: The available published literature fails to support an association...

...Mickaël Bobot; Jean-François Hak; Barbara Casolla; Jean-Daniel Dehondt; Stéphane Burtey; Emilie Doche; Laurent Suissa Introduction: Patients with chronic kidney disease (CKD) have an increased risk of stroke, and CKD seems associated with worse outcome after a stroke. The main objective of our...

...Justine Serre; Alice Doreille; Laure Raymond; Gaspard Suc; Mickaël Bobot; Marine Dancer; Cédric Rafat; Laurent Mesnard Introduction: Hypertensive nephrosclerosis (HN) ranks as one of the most frequent causes of chronic kidney disease (CKD), but its very existence has repeatedly been called...

...Nagarjunachary Ragi; Kumar Sharma Background: Chronic kidney disease (CKD) presents a persistent global health challenge, characterized by complex pathophysiology and diverse progression patterns. Metabolomics has emerged as a valuable tool in unraveling the intricate molecular mechanisms driving...

...Joseph Stavas; Arnold L. Silva; Thomas D. Wooldridge; Ahmed Aqeel; Theodore Saad; Rachita Prakash; George Bakris Introduction: Autologous cell-based therapies (CBT) to treat chronic kidney disease (CKD) with diabetes are novel and can potentially preserve renal function and decelerate disease...

...Ashley D. Troutman; Shruthi Srinivasan; Corinne E. Metzger; Paul B. Fallen; Neal Chen; Kalisha D. O'Neill; Matthew R. Allen; Annabel Biruete; Sharon M. Moe; Keith G. Avin Introduction: Chronic kidney disease (CKD) negatively affects musculoskeletal health, leading to reduced mobility...

... , Xu Y , Shang L . Association between serum klotho and all-cause mortality in chronic kidney disease: evidence from a prospective cohort study . Am J Nephrol . 2023 . In press. 2. Kovesdy CP . Epidemiology of chronic kidney disease: an update 2022 . Kidney Int Suppl . 2022...

...Valerie A. Luyckx; Ayah Elmaghrabi; Manisha Sahay; Nicole Scholes-Robertson; Laura Sola; Tobias Speare; Elliot K. Tannor; Katherine R. Tuttle; Ikechi G. Okpechi Background: Chronic kidney disease (CKD) is an important but insufficiently recognized public health problem. Unprecedented advances...

...Shisheng Han; Xiaolu Zhang; Xiaojun Wang; Yi Wang; Yanqiu Xu; Li Shang Introduction: This study aimed to investigate the relationship between circulating soluble Klotho concentration and all-cause mortality in individuals with chronic kidney disease (CKD). Methods: We conducted a prospective cohort...

...Elias John Elenjickal; Christoforos K. Travlos; Pedro Marques; Thomas A. Mavrakanas Background: Both atrial fibrillation and venous thromboembolism (VTE) are highly prevalent among patients with chronic kidney disease (CKD). Until recently, warfarin was the most commonly prescribed oral...

...Li Qin Gao; Can Can Xue; Jing Cui; Jie Xu; Chun Zhang; Dong Ning Chen; Jost B. Jonas; Ya Xing Wang Introduction: The aim of the study was to investigate associations between diabetic retinopathy (DR) and chronic kidney disease (CKD) in patients with type 2 diabetes (TD2). Methods: The participants...

... advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. 2023 Chronic kidney disease Integrated...

... under investigation for chronic kidney disease (CKD). Methods: This multinational, phase II, double-blind study (NCT05182840) investigated the efficacy and safety of daily oral BI 690517, with or without empagliflozin 10 mg, in participants with CKD. The primary endpoint was change from baseline...

... and cardiovascular events in patients with chronic kidney disease. We hypothesized that the prediction of ESA resistance during ESA administration would be very useful in deciding on a treatment plan. Methods: Patients enrolled in a randomized controlled trial to evaluate renal prognosis in anemic patients with non...